Correlation Between Orgenesis and OnKure Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orgenesis and OnKure Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orgenesis and OnKure Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orgenesis and OnKure Therapeutics,, you can compare the effects of market volatilities on Orgenesis and OnKure Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orgenesis with a short position of OnKure Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orgenesis and OnKure Therapeutics,.

Diversification Opportunities for Orgenesis and OnKure Therapeutics,

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Orgenesis and OnKure is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Orgenesis and OnKure Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OnKure Therapeutics, and Orgenesis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orgenesis are associated (or correlated) with OnKure Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OnKure Therapeutics, has no effect on the direction of Orgenesis i.e., Orgenesis and OnKure Therapeutics, go up and down completely randomly.

Pair Corralation between Orgenesis and OnKure Therapeutics,

If you would invest  122.00  in Orgenesis on September 22, 2024 and sell it today you would earn a total of  0.00  from holding Orgenesis or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy4.65%
ValuesDaily Returns

Orgenesis  vs.  OnKure Therapeutics,

 Performance 
       Timeline  
Orgenesis 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
OnKure Therapeutics, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Orgenesis and OnKure Therapeutics, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orgenesis and OnKure Therapeutics,

The main advantage of trading using opposite Orgenesis and OnKure Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orgenesis position performs unexpectedly, OnKure Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will offset losses from the drop in OnKure Therapeutics,'s long position.
The idea behind Orgenesis and OnKure Therapeutics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets